Journal articleInt J Cancer2019
Metformin and pancreatic cancer survival: Real effect or immortal time bias?
- Journal
- Int J Cancer
- Published
- 25 March 2019
- Citations
- 21
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
High heterogeneity has been reported among cohort studies investigating the association between metformin and pancreatic cancer survival. Immortal time bias may be one importance source of heterogeneity, as it is widely present in previous cohort studies and may severely impair the validity. … Excerpt only: this text is the publisher’s. Read it in full at the source.